• Diagnosis​ Info ​and​ ​General​ ​Questions

  GBT Launches Early Access Program for Voxelotor in Europe, Other Regions

  Posted by sickle-cell-forum-administrator on January 22, 2021 at 10:58 am

  

  Global Blood Therapeutics’ voxelotor is now available in Europe and other areas outside the U.S. for patients with hemolytic anemia associated with SCD. Read more here.

  What do you think of this news?

  sickle-cell-forum-administrator replied 3 years, 2 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply